about
The Concept of Hormesis in Cancer Therapy - Is Less More?Interactions between Autophagy and Bacterial Toxins: Targets for Therapy?STAT6-dependent and -independent mechanisms in Th2 polarizationLarge FK506-Binding Proteins Shape the Pharmacology of RapamycinRapalogs and mTOR inhibitors as anti-aging therapeuticsKinetics and protective role of autophagy in a mouse cecal ligation and puncture-induced sepsisCutting edge: generation of effector cells that localize to mucosal tissues and form resident memory CD8 T cells is controlled by mTOR.Transcriptome profiling of CTLs regulated by rapamycin using RNA-SeqmicroRNA-mediated regulation of mTOR complex components facilitates discrimination between activation and anergy in CD4 T cells.TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists.Pharmacological regulators of autophagy and their link with modulators of lupus diseaseBlockade of mTOR signaling via rapamycin combined with immunotherapy augments antiglioma cytotoxic and memory T-cell functions.Polymeric synthetic nanoparticles for the induction of antigen-specific immunological toleranceSMAD-PI3K-Akt-mTOR pathway mediates BMP-7 polarization of monocytes into M2 macrophages.β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8+ T cells through regulation of IL-10.Beyond adjuvants: immunomodulation strategies to enhance T cell immunityIntrinsic MyD88-Akt1-mTOR Signaling Coordinates Disparate Tc17 and Tc1 Responses during Vaccine Immunity against Fungal Pneumonia.Therapeutic implications of targeting the PI3Kinase/AKT/mTOR signaling module in melanoma therapy.Regulation and function of mTOR signalling in T cell fate decisions.The role of mTOR signaling pathway in spinal cord injury.Cyclosporin A inhibits colon cancer cell growth independently of the calcineurin pathway.Attenuation of AMPK signaling by ROQUIN promotes T follicular helper cell formation.p38α senses environmental stress to control innate immune responses via mechanistic target of rapamycinmTOR, linking metabolism and immunitymTOR: a link from the extracellular milieu to transcriptional regulation of oligodendrocyte development.Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells.The Vital Role of Pathology in Improving Reproducibility and Translational Relevance of Aging Studies in RodentsTreating brain tumor-initiating cells using a combination of myxoma virus and rapamycinAutism spectrum disorder causes, mechanisms, and treatments: focus on neuronal synapses.Drosophila as a model for the two myeloid blood cell systems in vertebrates.Increased mammalian target of rapamycin complex 2 signaling promotes age-related decline in CD4 T cell signaling and functionInvolvement of interleukin-1β in the autophagic process of microglia: relevance to Alzheimer's diseasePro-inflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids.Metabolic sensors and their interplay with cell signalling and transcription.Combining immunotherapy and targeted therapies in cancer treatment.The impact of infection and tissue damage in solid-organ transplantation.Homeostasis and the importance for a balance between AKT/mTOR activity and intracellular signaling.Immune responses of macrophages and dendritic cells regulated by mTOR signalling.Immunostimulatory activity of lifespan-extending agents.Dietary restriction and the pursuit of effective mimetics.
P2860
Q26800519-6AA829F5-A6B3-47D4-A563-6F5FECE787E7Q26801464-195D0D35-2ACC-4580-A922-E0FAFEEE85CBQ27001202-A6978F6E-7552-4C37-9FDE-6AE495B1FFF3Q27676039-754D157E-B8DA-4D64-8210-C6F4B1212F1DQ28286510-39905658-1A84-4FD6-AF6B-698C1920AF53Q33751153-0C3939DA-B810-45E5-9C5F-106DB2606523Q34053750-770754B1-3C6C-49EE-962B-F80061AAAA3AQ34345253-DA228D42-CF17-4CE3-B9B1-751944983A48Q34375186-231D38E6-3C82-445B-A20A-BBCC0F2AFA20Q34391710-8915FC5C-B4D7-4685-9A57-5D232AA3C338Q34402759-A322EA09-99E9-4D95-B0B8-C139281D3D12Q34647123-E917A5D4-A38D-4C51-9667-BD04CF3B7247Q34985424-3FC4476D-1B10-4DAE-8174-3FEF2881E577Q35078311-8FCCDF29-A809-4768-B960-7942699C385FQ35157036-0039A61E-51F9-4DFA-8D2E-F6D7802107FCQ35666506-3C3016C3-8F56-4000-A77E-8D6A39A7733AQ35772809-994B18E4-527B-4884-9240-E72BBB2A8F86Q35832894-7F257C94-FC39-4180-984A-F6C43E7FE10BQ36157753-98E947F7-AB2F-44EA-B5F7-19A51BE834A8Q36304099-F86F03DA-F6C1-47CA-842C-DDF189BC2C72Q36426504-D4F8B134-6FA5-4CAC-BFEF-3CBB3EA6AB02Q36473888-E8341827-AD25-4742-8B20-AF710B2E701AQ36586138-01BC6952-151F-4204-88B6-A54A3761234EQ36639768-D2274310-518C-43AF-B48C-B09CA33E7394Q36697506-E705A63C-C5AC-48C5-9157-53F5DDFBA917Q36733476-E86785FD-94E2-4866-8AF3-33CF8955D46EQ36809947-B495F22E-C3F7-4CFA-A8B2-0F180BEDCB3DQ36943893-F8A0731B-D71C-4F95-BC46-4B2767371BDAQ37068738-BC7AE78A-D80B-4CA9-8751-B242CC615EC8Q37235632-E824EA60-859F-4F15-9A5E-2810B81BE451Q37307472-9CCDAB92-1B88-43D2-8EAC-9F92DF394AB9Q37427068-5DCAEF58-9C44-4324-BF2C-891FA9BA88D5Q37483138-F3EBC44E-2BEE-4F28-8841-219FBE2D3C44Q37995716-6472D280-30A4-416B-9D61-9E25180669A3Q37995939-89DA30B4-556A-4FE6-A3E2-02F8C143A8F0Q38013050-CF96E237-0B7D-45E4-A06E-FA67F80C1254Q38017247-D63AFDE4-CB8E-4970-B6F9-E329FCCD8FF8Q38122223-105C4B7B-11C9-4133-B202-ABF587F04072Q38175673-5044B70A-1D33-4CC6-A9DD-10BB86EA2517Q38177394-D278FCE8-4CF1-4ACB-A203-27050BA8ACFB
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
TOR in the immune system.
@ast
TOR in the immune system.
@en
type
label
TOR in the immune system.
@ast
TOR in the immune system.
@en
prefLabel
TOR in the immune system.
@ast
TOR in the immune system.
@en
P2093
P2860
P1476
TOR in the immune system.
@en
P2093
Ali H Ellebedy
Koichi Araki
Rafi Ahmed
P2860
P304
P356
10.1016/J.CEB.2011.08.006
P577
2011-09-16T00:00:00Z